152 related articles for article (PubMed ID: 32005121)
1. Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells.
Oono K; Ohtake K; Watanabe C; Shiba S; Sekiya T; Kasono K
Lipids Health Dis; 2020 Jan; 19(1):15. PubMed ID: 32005121
[TBL] [Abstract][Full Text] [Related]
2. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PC3 human prostate cancer cell proliferation, invasion and migration by eicosapentaenoic acid and docosahexaenoic acid.
Oono K; Takahashi K; Sukehara S; Kurosawa H; Matsumura T; Taniguchi S; Ohta S
Mol Clin Oncol; 2017 Aug; 7(2):217-220. PubMed ID: 28781788
[TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic acid (EPA) induced apoptosis in HepG2 cells through ROS-Ca(2+)-JNK mitochondrial pathways.
Zhang Y; Han L; Qi W; Cheng D; Ma X; Hou L; Cao X; Wang C
Biochem Biophys Res Commun; 2015 Jan; 456(4):926-32. PubMed ID: 25529445
[TBL] [Abstract][Full Text] [Related]
5. Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages.
Li CC; Hou YC; Yeh CL; Yeh SL
PLoS One; 2014; 9(6):e99630. PubMed ID: 24925287
[TBL] [Abstract][Full Text] [Related]
6. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
Yin Y; Sui C; Meng F; Ma P; Jiang Y
Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of eicosapentaenoic acid (EPA) on the hypoxia/reoxygenation-induced tyrosine kinase activation in cultured human umbilical vein endothelial cells.
Zhang YW; Yao XS; Murota S; Morita I
Prostaglandins Leukot Essent Fatty Acids; 2002 Oct; 67(4):253-61. PubMed ID: 12401440
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2.
Nikolakopoulou Z; Nteliopoulos G; Michael-Titus AT; Parkinson EK
Carcinogenesis; 2013 Dec; 34(12):2716-25. PubMed ID: 23892603
[TBL] [Abstract][Full Text] [Related]
9. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.
Katsume A; Okigaki M; Matsui A; Che J; Adachi Y; Kishita E; Yamaguchi S; Ikeda K; Ueyama T; Matoba S; Yamada H; Matsubara H
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1084-92. PubMed ID: 21372295
[TBL] [Abstract][Full Text] [Related]
10. Polyunsaturated fatty acids inhibit melanoma cell growth in vitro.
Zajdel A; Wilczok A; Chodurek E; Gruchlik A; Dzierzewicz Z
Acta Pol Pharm; 2013; 70(2):365-9. PubMed ID: 23614295
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion.
Brown I; Lee J; Sneddon AA; Cascio MG; Pertwee RG; Wahle KWJ; Rotondo D; Heys SD
Prostaglandins Leukot Essent Fatty Acids; 2020 May; 156():102024. PubMed ID: 31679810
[TBL] [Abstract][Full Text] [Related]
12. In vitro modulatory effect of omega-3 polyunsaturated fatty acid (EPA and DHA) on phagocytosis and ROS production of goat neutrophils.
Pisani LF; Lecchi C; Invernizzi G; Sartorelli P; Savoini G; Ceciliani F
Vet Immunol Immunopathol; 2009 Sep; 131(1-2):79-85. PubMed ID: 19395090
[TBL] [Abstract][Full Text] [Related]
13. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species abrogate the anticarcinogenic effect of eicosapentaenoic acid in Atm-deficient mice.
Schubert R; Reichenbach J; Koch C; Kloess S; Koehl U; Mueller K; Baer P; Beermann C; Boehles H; Zielen S
Nutr Cancer; 2010; 62(5):584-92. PubMed ID: 20574919
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion.
Khalfoun B; Thibault G; Bardos P; Lebranchu Y
Transplantation; 1996 Dec; 62(11):1649-57. PubMed ID: 8970622
[TBL] [Abstract][Full Text] [Related]
16. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
17. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation.
Sam MR; Ahangar P; Nejati V; Habibian R
Cell Oncol (Dordr); 2016 Feb; 39(1):69-77. PubMed ID: 26671842
[TBL] [Abstract][Full Text] [Related]
18. EPA, an omega-3 fatty acid, induces apoptosis in human pancreatic cancer cells: role of ROS accumulation, caspase-8 activation, and autophagy induction.
Fukui M; Kang KS; Okada K; Zhu BT
J Cell Biochem; 2013 Jan; 114(1):192-203. PubMed ID: 22903547
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
20. Toyocamycin induces apoptosis via the crosstalk between reactive oxygen species and p38/ERK MAPKs signaling pathway in human prostate cancer PC-3 cells.
Park SG; Kim SH; Kim KY; Yu SN; Choi HD; Kim YW; Nam HW; Seo YK; Ahn SC
Pharmacol Rep; 2017 Feb; 69(1):90-96. PubMed ID: 27912102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
